Keywords: sucampo, profit, up, amitiza, revenue, usa-based, pharmaceuticals
Sucampo profit up 89% on Amitiza revenue
Article | 02 March 2009
USA-based Sucampo Pharmaceuticals' profit rocketed 89%, year-on-year for 2008, due to rising revenues from its collaboration with Abbott and Japan's Takeda.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
